Triple

T7157008
Position Surface form Disambiguated ID Type / Status
Subject Exicure, Inc. E166837 entity
Predicate hasCollaborationWith P398 FINISHED
Object Allergan (prior to its acquisition by AbbVie) E474948 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Allergan (prior to its acquisition by AbbVie) | Statement: [Exicure, Inc., hasCollaborationWith, Allergan (prior to its acquisition by AbbVie)]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Allergan (prior to its acquisition by AbbVie)
Context triple: [Exicure, Inc., hasCollaborationWith, Allergan (prior to its acquisition by AbbVie)]
  • A. Allergan chosen
    Allergan is a global pharmaceutical company best known for developing branded drugs and medical aesthetics products, including Botox.
  • B. AbbVie
    AbbVie is a global biopharmaceutical company known for developing and marketing innovative therapies in areas such as immunology, oncology, and neuroscience.
  • C. Abbott Laboratories
    Abbott Laboratories is a global healthcare company that develops and manufactures medical devices, diagnostics, branded generic medicines, and nutritional products.
  • D. Novartis
    Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
  • E. Bristol Myers Squibb
    Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c68887a5cc8190bec0ea96227164f7 completed March 27, 2026, 1:39 p.m.
NER Named-entity recognition batch_69c6e80f14808190907ee84523630d85 completed March 27, 2026, 8:26 p.m.
NED1 Entity disambiguation (via context triple) batch_69c7adb530388190b68fa05418d3e184 completed March 28, 2026, 10:30 a.m.
Created at: March 27, 2026, 2:47 p.m.